APC Mouse IgG2b Isotype Control (MPC-11)
IgG2b Isotype Control Monoclonal Antibody for FC
Host / Isotype
Mouse / IgG2b
Reactivity
Applications
FC
Conjugate
APC Fluorescent Dye
CloneNo.
MPC-11
Cat no : APC-65128
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | human PBMCs |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
FC | See 3 publications below |
Product Information
APC-65128 targets IgG2b Isotype Control in FC applications and shows reactivity with samples.
Tested Reactivity | |
Cited Reactivity | human |
Host / Isotype | Mouse / IgG2b |
Class | Monoclonal |
Type | Antibody |
Immunogen | N/A |
Full Name | immunoglobulin heavy chain 3 (serum IgG2b) |
Gene Symbol | IgG2b Isotype Control |
Gene ID (NCBI) | 16016 |
RRID | AB_2883011 |
Conjugate | APC Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 650 nm / 660 nm |
Form | Liquid |
Purification Method | Affinity purification |
Storage Buffer | PBS with 0.09% sodium azide and 0.5% BSA. |
Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Background Information
The MPC-11 immunoglobulin is useful as an isotype-matched control. The MPC-11 immunoglobulin has an unknown binding specificity and is used as an isotype control for mouse IgG2b antibodies. This antibody has been quality-tested for flow cytometry as negative control.
Protocols
Product Specific Protocols | |
---|---|
FC protocol for APC IgG2b Isotype Control antibody APC-65128 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
MedComm (2020) CircMALAT1 promotes cancer stem-like properties and chemoresistance via regulating Musashi-2/c-Myc axis in esophageal squamous cell carcinoma | ||
Eur J Pharmacol PPARγ agonist pioglitazone enhances colorectal cancer immunotherapy by inducing PD-L1 autophagic degradation | ||
Auris Nasus Larynx Simultaneous disturbance of NHE1 and LOXL2 decreases tumorigenicity of head and neck squamous cell carcinoma |